03/09/2026
Lots of amazing work was on show at ANZUP ASM 2026 (28-30 June), showing off some of the GU registries and their real-world data in action!
Awarded Best Poster were:
🌟BLADDA registry: Dr Andrisha Inderjeeth presented on first-line treatment with Avelumab for metastatic urothelial bladder cancer and barriers limiting uptake of new 1L therapies
🌟ePAD registry: Dr Anthony Uccellini discussed real-world patterns of molecular testing in Australian patients with metastatic CRPC.
🌟ePAD registry: Dr Tivya Kulasegaran explored re-thinking treatment intensity, comparing real-world PSA kinetics with ARPI doublet versus docetaxel triplet in metastatic hormone-sensitive prostate cancer
🌟KRAB registry: In patients with metastatic clear cell renal call carcinoma, Dr Faria Arefin’s findings suggest treatment with ipilimumab and nivolumab leads to durable response in ~25% of patients.